Belgium supplies 51.3% of U.S. imports of Vaccines for Human Medicine, across 24 countries (year to date through August 2026).
HHI 3,078 of 10,000 · HHI above 1,800. The sum of each country’s squared percentage share; one country with everything scores 10,000.
24 countries supplying this product to the U.S.
| Rank# | Country | Value | Share | YoY | Duty |
|---|---|---|---|---|---|
| 1 | Italy | $235.3M | 36.9% | +17.0% | 0.0% |
| 2 | Spain | $93.3M | 14.6% | +15382.9% | 0.0% |
| 3 | Denmark | $68.6M | 10.8% | +317.1% | 0.0% |
| 4 | Canada | $61.3M | 9.6% | -33.0% | 0.0% |
| 5 | Belgium | $55.3M | 8.7% | +32.2% | 0.0% |
| 6 | Germany | $34.3M | 5.4% | -52.0% | 0.0% |
| 7 | France | $21.3M | 3.3% | -42.1% | 0.0% |
| 8 | Taiwan | $18.2M | 2.9% | +17.8% | 0.0% |
| 9 | Ireland | $16.5M | 2.6% | -67.9% | <0.1% |
| 10 | India | $14.7M | 2.3% | +421.5% | 0.0% |
| 11 | United Kingdom | $7.6M | 1.2% | +7.1% | 0.0% |
| 12 | Switzerland | $5.6M | 0.9% | +24.4% | 0.0% |
| 13 | Japan | $3.1M | 0.5% | -8.7% | 0.0% |
| 14 | Austria | $2.8M | 0.5% | +2.8% | 0.0% |
| 15 | China | $158K | <0.1% | -- | 0.0% |
| 16 | Australia | $117K | <0.1% | -93.5% | 0.0% |
| 17 | Thailand | -- | 0.0% | -12.0% | -- |
| 18 | Singapore | -- | 0.0% | -- | -- |
| 19 | Sweden | -- | 0.0% | -- | -- |
| 20 | South Korea | -- | 0.0% | -94.7% | -- |
| 21 | Mexico | -- | 0.0% | +335.6% | -- |
| 22 | Netherlands | -- | 0.0% | -69.5% | -- |
| 23 | Brazil | -- | 0.0% | -65.8% | -- |
| 24 | South Africa | -- | 0.0% | +40.1% | -- |
Duty is the duty Census calculated on this month's imports for consumption from each country, as a share of their customs value. It applies the rates in force, additional duties such as Section 301, 232 and IEEPA included and claimed trade-agreement preferences netted out, so it is an observed rate rather than a statutory one. It is an estimate, not duty collected: antidumping and countervailing duties, fees and later refunds are not in it. YoY compares year-to-date value with the same months last year.